Caris Life Sciences Raises FY2026 Sales Guidance from $1.030B-$1.040B to $1.040B-$1.050B vs $1.030B Est
Caris Life Sciences (NASDAQ:CAI) raises FY2026 sales outlook from $1.030 billion-$1.040 billion to $1.040 billion-$1.050 billion vs $1.030 billion estimate.
Caris Life Sciences said it will make a bit more money next year than it thought before. When a company raises its money forecast, it usually means business is going better than expected.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.